Exact Mass: 550.2437

Manumycin A

C31H38N2O7 (550.2679)

A polyketide with formula C31H38N2O7 initially isolated from Streptomyces parvulus as a result of a random screening program for farnesyl transferase (FTase) inhibitors. It is a natural product that exhibits anticancer and antibiotic properties. Manumycin A is a polyketide with formula C31H38N2O7 initially isolated from Streptomyces parvulus as a result of a random screening program for farnesyl transferase (FTase) inhibitors. It is a natural product that exhibits anticancer and antibiotic properties. It has a role as an EC 1.8.1.9 (thioredoxin reductase) inhibitor, an EC 2.5.1.58 (protein farnesyltransferase) inhibitor, an antineoplastic agent, an apoptosis inducer, an antimicrobial agent, a bacterial metabolite, an antiatherosclerotic agent and a marine metabolite. It is a polyketide, an enamide, an epoxide, an organic heterobicyclic compound, a secondary carboxamide and a tertiary alcohol. Manumycin A is a natural product found in Streptomyces, Streptomyces griseoaurantiacus, and Streptomyces parvulus D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors

Lappaol B

C31H34O9 (550.2203)

Manumycin A

C31H38N2O7 (550.2679)

Fantofarone

C31H38N2O5S (550.2501)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

PA(2:0/PGF2alpha)

C25H43O11P (550.2543)

PA(2:0/PGF2alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGF2alpha), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin F2alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGF2alpha/2:0)

C25H43O11P (550.2543)

PA(PGF2alpha/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGF2alpha/2:0), in particular, consists of one chain of one Prostaglandin F2alpha at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/PGE1)

C25H43O11P (550.2543)

PA(2:0/PGE1) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGE1), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin E1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGE1/2:0)

C25H43O11P (550.2543)

PA(PGE1/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGE1/2:0), in particular, consists of one chain of one Prostaglandin E1 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/PGD1)

C25H43O11P (550.2543)

PA(2:0/PGD1) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGD1), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin D1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGD1/2:0)

C25H43O11P (550.2543)

PA(PGD1/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGD1/2:0), in particular, consists of one chain of one Prostaglandin D1 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Lappaol B

C31H34O9 (550.2203)

Lappaol b is a member of the class of compounds known as 2-arylbenzofuran flavonoids. 2-arylbenzofuran flavonoids are phenylpropanoids containing the 2-phenylbenzofuran moiety. Lappaol b is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Lappaol b can be found in burdock, which makes lappaol b a potential biomarker for the consumption of this food product.

Junceellolide D

C28H38O11 (550.2414)

Milolide M

C28H38O11 (550.2414)

Decinnamoyltaxinine B 11,12-epoxide

C28H38O11 (550.2414)

Excavatolide G

C28H38O11 (550.2414)

Tasumatrol N

C28H38O11 (550.2414)

Mortonol B

C31H34O9 (550.2203)

Taxumairol I

C28H38O11 (550.2414)

Frajunolide E

C28H38O11 (550.2414)

pseudolaric acid A O-beta-d-glucopyranoside

C28H38O11 (550.2414)

Pseudolaric acid A-O-β-D-glucopyranoside, isolated from Cortex Pseudolaricis, demonstrates antifungal and antifertility activities[1]. Pseudolaric acid A-O-β-D-glucopyranoside, isolated from Cortex Pseudolaricis, demonstrates antifungal and antifertility activities[1].

Tetrahelin C

C28H38O11 (550.2414)

Pachyclavulide H

C28H38O11 (550.2414)

Tigloylseneganolide A

C32H38O8 (550.2567)

N-Desmethyl-N-benzyl sildenafil

C28H34N6O4S (550.2362)

Triptogelin A-4

C31H34O9 (550.2203)

helioxenicin B

C28H38O11 (550.2414)

Alpinnanin C

C35H34O6 (550.2355)

achicollinolide

C32H38O8 (550.2567)

tricalysionoside A

C25H42O13 (550.2625)

(1R*,2R*,3S*,5Z,7S*,8S*,9S*,10S*,11R*,12S*,14S*,17R*)-2,3,14-triacetoxy-8,9,11,12-bisepoxy-17-hydroxybriar-5-en-18-one

C28H38O11 (550.2414)

16-oxo-heteroclitalactone H|heteroclitalactone K

C32H38O8 (550.2567)

17-hydroxyingenol 17-benzoate-20-angelate

C32H38O8 (550.2567)

C25H42O13

C25H42O13 (550.2625)

(2E)-1-{2,4-dihydroxy-3-[(1R,2E,5R)-5-hydroxy-1-(4-hydroxyphenyl)-7-phenyl-2-hepten-1-yl]-6-methoxyphenyl}-3-phenyl-2-propen-1-one|Alpinnanin B|ent-alpinnanin B

C35H34O6 (550.2355)

michaolide J

C28H38O11 (550.2414)

A cembrane diterpenoid with cytotoxic activity isolated from the soft coral Lobophytum michaelae.

(1R,3aS,4Z,8S,8aR,9S,12aS,13S,13aR)-8,9,13-tris(acetyloxy)-5-[(acetyloxy)methyl]-3a,6,7,8,8a,9,10,11,12,12a,13,13a-dodecahydro-13a-hydroxy-1,8a-dimethyl-12-methylidenebenzo[4,5]cyclodeca[1,2-b]furan-2(1H)-one|junceellonoid B

C28H38O11 (550.2414)

C32H38O8

C32H38O8 (550.2567)

(3S,5R,6S,7E,9S)-megastigman-7-ene-5,6-epoxy-3,9-diol

C25H42O13 (550.2625)

Magnolignan H

C35H34O6 (550.2355)

balgacyclamide b

C25H38N6O6S (550.2573)

4-acetate-1,2,3,5-tetrakis(2-methyl-2-butenoate)inositol

C28H38O11 (550.2414)

3-acetate-1,2,4,5-tetrakis(2-methyl-2-butenoate)inositol

C28H38O11 (550.2414)

artanomadimer D

C32H38O8 (550.2567)

7beta,9,10beta,20-tetracetoxy-13beta,17-epoxy-3,8-secotaxa-3E,8E,11-triene-2alpha,5alpha-diol|canataxpyran A

C28H38O11 (550.2414)

artanomadimer B

C32H38O8 (550.2567)

1-O-cinnamoyl-17-defurano-17-oxosalannicacid methyl ester|17-defurano-17-oxoohchinin

C32H38O8 (550.2567)

MS000164985

C28H38O11 (550.2414)

3-O-angeloyl-17-(benzoyloxy)ingenol|ingenol-3-angelate-17-benzoate

C32H38O8 (550.2567)

5-O-angeloyl-17-O-benzoylingenol

C32H38O8 (550.2567)

FT-0775947

C28H38O11 (550.2414)

1, 1-[[2, 4-Bis(6-methoxy-1, 3-benzodioxol-5-yl)-1, 3-cyclobutanediyl]dicarbonyl]bispyrrolidine, 9CI

C30H34N2O8 (550.2315)

Lappaol A

C31H34O9 (550.2203)

15-hydroxysolanascone-beta-glucopyranoside tetraacetate

C28H38O11 (550.2414)

(1R*,3aS*,4Z,8S*,8aS*,9S*,11R*,12aS*,13S*,13aS*)-1,2,3a,6,7,8,8a,9,10,11,12,12a,13,13a-tetradecahydro-13a-hydroxy-1,5,8a-trimethyl-12-methylidene-2-oxobenzo[4,5]cyclodeca[1,2-b]furan-8,9,11,13-tetrayl tetraacetate|frajunolide A|rel-(1S,2S,5Z,7S,8S,9S,10S,12R,14S,17R)-2,9,12,14-tetraacetoxy-8-hydroxybriara-5,11(20)-dien-18,7-olide

C28H38O11 (550.2414)

Ser Ala Lys Asp Met

C21H38N6O9S (550.2421)

Leu Glu Phe Glu

C26H38N4O9 (550.2639)

Gln Phe Glu Lys

C25H38N6O8 (550.2751)

Lys Gln Phe Glu

C25H38N6O8 (550.2751)

PseudolaricacidAbeta-D-glucoside

C28H38O11 (550.2414)

PseudolaricacidAbeta-D-glucoside is a natural product found in Pseudolarix amabilis and Larix kaempferi with data available. Pseudolaric acid A-O-β-D-glucopyranoside, isolated from Cortex Pseudolaricis, demonstrates antifungal and antifertility activities[1]. Pseudolaric acid A-O-β-D-glucopyranoside, isolated from Cortex Pseudolaricis, demonstrates antifungal and antifertility activities[1].

Versicotide C

C28H34N6O6 (550.254)

Ala Phe Gln Trp

C28H34N6O6 (550.254)

Ala Phe Trp Gln

C28H34N6O6 (550.254)

Ala Gln Phe Trp

C28H34N6O6 (550.254)

Ala Gln Trp Phe

C28H34N6O6 (550.254)

Ala Trp Phe Gln

C28H34N6O6 (550.254)

Ala Trp Gln Phe

C28H34N6O6 (550.254)

Cys Asp Lys Trp

C24H34N6O7S (550.221)

Cys Asp Trp Lys

C24H34N6O7S (550.221)

Cys Lys Asp Trp

C24H34N6O7S (550.221)

Cys Lys Trp Asp

C24H34N6O7S (550.221)

Cys Arg Ser Trp

C23H34N8O6S (550.2322)

Cys Arg Trp Ser

C23H34N8O6S (550.2322)

Cys Ser Arg Trp

C23H34N8O6S (550.2322)

Cys Ser Trp Arg

C23H34N8O6S (550.2322)

Cys Trp Asp Lys

C24H34N6O7S (550.221)

Cys Trp Lys Asp

C24H34N6O7S (550.221)

Cys Trp Arg Ser

C23H34N8O6S (550.2322)

Cys Trp Ser Arg

C23H34N8O6S (550.2322)

Asp Cys Lys Trp

C24H34N6O7S (550.221)

Asp Cys Trp Lys

C24H34N6O7S (550.221)

Asp Phe Asn Arg

C23H34N8O8 (550.2499)

Asp Phe Arg Asn

C23H34N8O8 (550.2499)

Asp Lys Cys Trp

C24H34N6O7S (550.221)

Asp Lys Trp Cys

C24H34N6O7S (550.221)

Asp Asn Phe Arg

C23H34N8O8 (550.2499)

Asp Asn Arg Phe

C23H34N8O8 (550.2499)

Asp Arg Phe Asn

C23H34N8O8 (550.2499)

Asp Arg Asn Phe

C23H34N8O8 (550.2499)

Asp Trp Cys Lys

C24H34N6O7S (550.221)

Asp Trp Lys Cys

C24H34N6O7S (550.221)

Glu Glu His His

C22H30N8O9 (550.2136)

Glu Phe Lys Gln

C25H38N6O8 (550.2751)

Glu Phe Gln Lys

C25H38N6O8 (550.2751)

Glu Phe Gln Gln

C24H34N6O9 (550.2387)

Glu His Glu His

C22H30N8O9 (550.2136)

Glu His His Glu

C22H30N8O9 (550.2136)

Glu Lys Phe Gln

C25H38N6O8 (550.2751)

Glu Lys Gln Phe

C25H38N6O8 (550.2751)

Glu Gln Phe Lys

C25H38N6O8 (550.2751)

Glu Gln Phe Gln

C24H34N6O9 (550.2387)

Glu Gln Lys Phe

C25H38N6O8 (550.2751)

Glu Gln Gln Phe

C24H34N6O9 (550.2387)

Phe Ala Gln Trp

C28H34N6O6 (550.254)

Phe Ala Trp Gln

C28H34N6O6 (550.254)

Phe Asp Asn Arg

C23H34N8O8 (550.2499)

Phe Asp Arg Asn

C23H34N8O8 (550.2499)

Phe Glu Lys Gln

C25H38N6O8 (550.2751)

Phe Glu Gln Lys

C25H38N6O8 (550.2751)

Phe Glu Gln Gln

C24H34N6O9 (550.2387)

Phe Phe His Thr

C28H34N6O6 (550.254)

Phe Phe Thr His

C28H34N6O6 (550.254)

Phe His Phe Thr

C28H34N6O6 (550.254)

Phe His Thr Phe

C28H34N6O6 (550.254)

Phe Lys Glu Gln

C25H38N6O8 (550.2751)

Phe Lys Gln Glu

C25H38N6O8 (550.2751)

Phe Asn Asp Arg

C23H34N8O8 (550.2499)

Phe Asn Arg Asp

C23H34N8O8 (550.2499)

Phe Gln Ala Trp

C28H34N6O6 (550.254)

Phe Gln Glu Lys

C25H38N6O8 (550.2751)

Phe Gln Glu Gln

C24H34N6O9 (550.2387)

Phe Gln Lys Glu

C25H38N6O8 (550.2751)

Phe Gln Gln Glu

C24H34N6O9 (550.2387)

Phe Gln Trp Ala

C28H34N6O6 (550.254)

Phe Arg Asp Asn

C23H34N8O8 (550.2499)

Phe Arg Asn Asp

C23H34N8O8 (550.2499)

Phe Thr Phe His

C28H34N6O6 (550.254)

Phe Thr His Phe

C28H34N6O6 (550.254)

Phe Trp Ala Gln

C28H34N6O6 (550.254)

Phe Trp Gln Ala

C28H34N6O6 (550.254)

His Glu Glu His

C22H30N8O9 (550.2136)

His Glu His Glu

C22H30N8O9 (550.2136)

His Phe Phe Thr

C28H34N6O6 (550.254)

His Phe Thr Phe

C28H34N6O6 (550.254)

His His Glu Glu

C22H30N8O9 (550.2136)

His Met Thr Tyr

C24H34N6O7S (550.221)

His Met Tyr Thr

C24H34N6O7S (550.221)

His Thr Phe Phe

C28H34N6O6 (550.254)

His Thr Met Tyr

C24H34N6O7S (550.221)

His Thr Tyr Met

C24H34N6O7S (550.221)

His Tyr Met Thr

C24H34N6O7S (550.221)

His Tyr Thr Met

C24H34N6O7S (550.221)

Ile Gln Gln Tyr

C25H38N6O8 (550.2751)

Ile Gln Tyr Gln

C25H38N6O8 (550.2751)

Ile Tyr Gln Gln

C25H38N6O8 (550.2751)

Lys Cys Asp Trp

C24H34N6O7S (550.221)

Lys Cys Trp Asp

C24H34N6O7S (550.221)

Lys Asp Cys Trp

C24H34N6O7S (550.221)

Lys Asp Trp Cys

C24H34N6O7S (550.221)

Lys Glu Phe Gln

C25H38N6O8 (550.2751)

Lys Glu Gln Phe

C25H38N6O8 (550.2751)

Lys Phe Glu Gln

C25H38N6O8 (550.2751)

Lys Phe Gln Glu

C25H38N6O8 (550.2751)

Lys Met Ser Trp

C25H38N6O6S (550.2573)

Lys Met Trp Ser

C25H38N6O6S (550.2573)

Lys Gln Glu Phe

C25H38N6O8 (550.2751)

Lys Ser Met Trp

C25H38N6O6S (550.2573)

Lys Ser Trp Met

C25H38N6O6S (550.2573)

Lys Trp Cys Asp

C24H34N6O7S (550.221)

Lys Trp Asp Cys

C24H34N6O7S (550.221)

Lys Trp Met Ser

C25H38N6O6S (550.2573)

Lys Trp Ser Met

C25H38N6O6S (550.2573)

Leu Gln Gln Tyr

C25H38N6O8 (550.2751)

Leu Gln Tyr Gln

C25H38N6O8 (550.2751)

Leu Tyr Gln Gln

C25H38N6O8 (550.2751)

Met His Thr Tyr

C24H34N6O7S (550.221)

Met His Tyr Thr

C24H34N6O7S (550.221)

Met Lys Ser Trp

C25H38N6O6S (550.2573)

Met Lys Trp Ser

C25H38N6O6S (550.2573)

Met Met Asn Arg

C20H38N8O6S2 (550.2356)

Met Met Arg Asn

C20H38N8O6S2 (550.2356)

Met Asn Met Arg

C20H38N8O6S2 (550.2356)

Met Asn Arg Met

C20H38N8O6S2 (550.2356)

Met Asn Thr Trp

C24H34N6O7S (550.221)

Met Asn Trp Thr

C24H34N6O7S (550.221)

Met Gln Ser Trp

C24H34N6O7S (550.221)

Met Gln Trp Ser

C24H34N6O7S (550.221)

Met Arg Met Asn

C20H38N8O6S2 (550.2356)

Met Arg Asn Met

C20H38N8O6S2 (550.2356)

Met Ser Lys Trp

C25H38N6O6S (550.2573)

Met Ser Gln Trp

C24H34N6O7S (550.221)

Met Ser Trp Lys

C25H38N6O6S (550.2573)

Met Ser Trp Gln

C24H34N6O7S (550.221)

Met Thr His Tyr

C24H34N6O7S (550.221)

Met Thr Asn Trp

C24H34N6O7S (550.221)

Met Thr Trp Asn

C24H34N6O7S (550.221)

Met Thr Tyr His

C24H34N6O7S (550.221)

Met Trp Lys Ser

C25H38N6O6S (550.2573)

Met Trp Asn Thr

C24H34N6O7S (550.221)

Met Trp Gln Ser

C24H34N6O7S (550.221)

Met Trp Ser Lys

C25H38N6O6S (550.2573)

Met Trp Ser Gln

C24H34N6O7S (550.221)

Met Trp Thr Asn

C24H34N6O7S (550.221)

Met Tyr His Thr

C24H34N6O7S (550.221)

Met Tyr Thr His

C24H34N6O7S (550.221)

Asn Asp Phe Arg

C23H34N8O8 (550.2499)

Asn Asp Arg Phe

C23H34N8O8 (550.2499)

Asn Phe Asp Arg

C23H34N8O8 (550.2499)

Asn Phe Arg Asp

C23H34N8O8 (550.2499)

Asn Met Met Arg

C20H38N8O6S2 (550.2356)

Asn Met Arg Met

C20H38N8O6S2 (550.2356)

Asn Met Thr Trp

C24H34N6O7S (550.221)

Asn Met Trp Thr

C24H34N6O7S (550.221)

Asn Arg Asp Phe

C23H34N8O8 (550.2499)

Asn Arg Phe Asp

C23H34N8O8 (550.2499)

Asn Arg Met Met

C20H38N8O6S2 (550.2356)

Asn Thr Met Trp

C24H34N6O7S (550.221)

Asn Thr Trp Met

C24H34N6O7S (550.221)

Asn Trp Met Thr

C24H34N6O7S (550.221)

Asn Trp Thr Met

C24H34N6O7S (550.221)

Gln Ala Phe Trp

C28H34N6O6 (550.254)

Gln Ala Trp Phe

C28H34N6O6 (550.254)

Gln Glu Phe Lys

C25H38N6O8 (550.2751)

Gln Glu Phe Gln

C24H34N6O9 (550.2387)

Gln Glu Lys Phe

C25H38N6O8 (550.2751)

Gln Glu Gln Phe

C24H34N6O9 (550.2387)

Gln Phe Ala Trp

C28H34N6O6 (550.254)

Gln Phe Glu Gln

C24H34N6O9 (550.2387)

Gln Phe Lys Glu

C25H38N6O8 (550.2751)

Gln Phe Gln Glu

C24H34N6O9 (550.2387)

Gln Phe Trp Ala

C28H34N6O6 (550.254)

Gln Ile Gln Tyr

C25H38N6O8 (550.2751)

Gln Ile Tyr Gln

C25H38N6O8 (550.2751)

Gln Lys Glu Phe

C25H38N6O8 (550.2751)

Gln Lys Phe Glu

C25H38N6O8 (550.2751)

Gln Leu Gln Tyr

C25H38N6O8 (550.2751)

Gln Leu Tyr Gln

C25H38N6O8 (550.2751)

Gln Met Ser Trp

C24H34N6O7S (550.221)

Gln Met Trp Ser

C24H34N6O7S (550.221)

Gln Gln Glu Phe

C24H34N6O9 (550.2387)

Gln Gln Phe Glu

C24H34N6O9 (550.2387)

Gln Gln Ile Tyr

C25H38N6O8 (550.2751)

Gln Gln Leu Tyr

C25H38N6O8 (550.2751)

Gln Gln Tyr Ile

C25H38N6O8 (550.2751)

Gln Gln Tyr Leu

C25H38N6O8 (550.2751)

Gln Ser Met Trp

C24H34N6O7S (550.221)

Gln Ser Trp Met

C24H34N6O7S (550.221)

Gln Trp Ala Phe

C28H34N6O6 (550.254)

Gln Trp Phe Ala

C28H34N6O6 (550.254)

Gln Trp Met Ser

C24H34N6O7S (550.221)

Gln Trp Ser Met

C24H34N6O7S (550.221)

Gln Tyr Ile Gln

C25H38N6O8 (550.2751)

Gln Tyr Leu Gln

C25H38N6O8 (550.2751)

Gln Tyr Gln Ile

C25H38N6O8 (550.2751)

Gln Tyr Gln Leu

C25H38N6O8 (550.2751)

Arg Cys Ser Trp

C23H34N8O6S (550.2322)

Arg Cys Trp Ser

C23H34N8O6S (550.2322)

Arg Asp Phe Asn

C23H34N8O8 (550.2499)

Arg Asp Asn Phe

C23H34N8O8 (550.2499)

Arg Phe Asp Asn

C23H34N8O8 (550.2499)

Arg Phe Asn Asp

C23H34N8O8 (550.2499)

Arg Met Met Asn

C20H38N8O6S2 (550.2356)

Arg Met Asn Met

C20H38N8O6S2 (550.2356)

Arg Asn Asp Phe

C23H34N8O8 (550.2499)

Arg Asn Phe Asp

C23H34N8O8 (550.2499)

Arg Asn Met Met

C20H38N8O6S2 (550.2356)

Arg Ser Cys Trp

C23H34N8O6S (550.2322)

Arg Ser Trp Cys

C23H34N8O6S (550.2322)

Arg Trp Cys Ser

C23H34N8O6S (550.2322)

Arg Trp Ser Cys

C23H34N8O6S (550.2322)

Ser Cys Arg Trp

C23H34N8O6S (550.2322)

Ser Cys Trp Arg

C23H34N8O6S (550.2322)

Ser Lys Met Trp

C25H38N6O6S (550.2573)

Ser Lys Trp Met

C25H38N6O6S (550.2573)

Ser Met Lys Trp

C25H38N6O6S (550.2573)

Ser Met Gln Trp

C24H34N6O7S (550.221)

Ser Met Trp Lys

C25H38N6O6S (550.2573)

Ser Met Trp Gln

C24H34N6O7S (550.221)

Ser Gln Met Trp

C24H34N6O7S (550.221)

Ser Gln Trp Met

C24H34N6O7S (550.221)

Ser Arg Cys Trp

C23H34N8O6S (550.2322)

Ser Arg Trp Cys

C23H34N8O6S (550.2322)

Ser Trp Cys Arg

C23H34N8O6S (550.2322)

Ser Trp Lys Met

C25H38N6O6S (550.2573)

Ser Trp Met Lys

C25H38N6O6S (550.2573)

Ser Trp Met Gln

C24H34N6O7S (550.221)

Ser Trp Gln Met

C24H34N6O7S (550.221)

Ser Trp Arg Cys

C23H34N8O6S (550.2322)

Thr Phe Phe His

C28H34N6O6 (550.254)

Thr Phe His Phe

C28H34N6O6 (550.254)

Thr His Phe Phe

C28H34N6O6 (550.254)

Thr His Met Tyr

C24H34N6O7S (550.221)

Thr His Tyr Met

C24H34N6O7S (550.221)

Thr Met His Tyr

C24H34N6O7S (550.221)

Thr Met Asn Trp

C24H34N6O7S (550.221)

Thr Met Trp Asn

C24H34N6O7S (550.221)

Thr Met Tyr His

C24H34N6O7S (550.221)

Thr Asn Met Trp

C24H34N6O7S (550.221)

Thr Asn Trp Met

C24H34N6O7S (550.221)

Thr Trp Met Asn

C24H34N6O7S (550.221)

Thr Trp Asn Met

C24H34N6O7S (550.221)

Thr Tyr His Met

C24H34N6O7S (550.221)

Thr Tyr Met His

C24H34N6O7S (550.221)

Trp Ala Phe Gln

C28H34N6O6 (550.254)

Trp Ala Gln Phe

C28H34N6O6 (550.254)

Trp Cys Asp Lys

C24H34N6O7S (550.221)

Trp Cys Lys Asp

C24H34N6O7S (550.221)

Trp Cys Arg Ser

C23H34N8O6S (550.2322)

Trp Cys Ser Arg

C23H34N8O6S (550.2322)

Trp Asp Cys Lys

C24H34N6O7S (550.221)

Trp Asp Lys Cys

C24H34N6O7S (550.221)

Trp Phe Ala Gln

C28H34N6O6 (550.254)

Trp Phe Gln Ala

C28H34N6O6 (550.254)

Trp Lys Cys Asp

C24H34N6O7S (550.221)

Trp Lys Asp Cys

C24H34N6O7S (550.221)

Trp Lys Met Ser

C25H38N6O6S (550.2573)

Trp Lys Ser Met

C25H38N6O6S (550.2573)

Trp Met Lys Ser

C25H38N6O6S (550.2573)

Trp Met Asn Thr

C24H34N6O7S (550.221)

Trp Met Gln Ser

C24H34N6O7S (550.221)

Trp Met Ser Lys

C25H38N6O6S (550.2573)

Trp Met Ser Gln

C24H34N6O7S (550.221)

Trp Met Thr Asn

C24H34N6O7S (550.221)

Trp Asn Met Thr

C24H34N6O7S (550.221)

Trp Asn Thr Met

C24H34N6O7S (550.221)

Trp Gln Ala Phe

C28H34N6O6 (550.254)

Trp Gln Phe Ala

C28H34N6O6 (550.254)

Trp Gln Met Ser

C24H34N6O7S (550.221)

Trp Gln Ser Met

C24H34N6O7S (550.221)

Trp Arg Cys Ser

C23H34N8O6S (550.2322)

Trp Arg Ser Cys

C23H34N8O6S (550.2322)

Trp Ser Cys Arg

C23H34N8O6S (550.2322)

Trp Ser Lys Met

C25H38N6O6S (550.2573)

Trp Ser Met Lys

C25H38N6O6S (550.2573)

Trp Ser Met Gln

C24H34N6O7S (550.221)

Trp Ser Gln Met

C24H34N6O7S (550.221)

Trp Ser Arg Cys

C23H34N8O6S (550.2322)

Trp Thr Met Asn

C24H34N6O7S (550.221)

Trp Thr Asn Met

C24H34N6O7S (550.221)

Tyr His Met Thr

C24H34N6O7S (550.221)

Tyr His Thr Met

C24H34N6O7S (550.221)

Tyr Ile Gln Gln

C25H38N6O8 (550.2751)

Tyr Leu Gln Gln

C25H38N6O8 (550.2751)

Tyr Met His Thr

C24H34N6O7S (550.221)

Tyr Met Thr His

C24H34N6O7S (550.221)

Tyr Gln Ile Gln

C25H38N6O8 (550.2751)

Tyr Gln Leu Gln

C25H38N6O8 (550.2751)

Tyr Gln Gln Ile

C25H38N6O8 (550.2751)

Tyr Gln Gln Leu

C25H38N6O8 (550.2751)

Tyr Thr His Met

C24H34N6O7S (550.221)

Tyr Thr Met His

C24H34N6O7S (550.221)

SAKDM

C21H38N6O9S (550.2421)

2,5-bis(tert-dodecyldithio)-1,3,4-thiadiazole

C26H50N2S5 (550.2577)

Suc-Ala-Ala-Val-Ala-pNA

C24H34N6O9 (550.2387)

lead(II) isodecanoate

C20H38O4Pb (550.2536)

lead ii neodecanoate

C20H38O4Pb (550.2536)

9,9-Bis[4-(2-oxiranemethyloxyethyloxy)phenyl]fluorene

C35H34O6 (550.2355)

H-D-Val-Leu-Lys-pNA · 2 HCl

C23H40Cl2N6O5 (550.2437)

benzene-1,3-dicarboxylic acid,2,2-dimethylpropane-1,3-diol,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,hexanedioic acid

C25H42O13 (550.2625)

ajugapantin A

C28H38O11 (550.2414)

A diterpene lactone isolated from the whole plants of Ajuga ciliata.

Des(isopropylthiazolyl) Hydantoin Ritonavir

C29H34N4O5S (550.225)

3-methoxy-6-(4-methoxyphenyl)-6-phenyl-Dibenzo[3,4:7,8]fluoreno[2,1-b]pyran-9(6H)-one

C38H30O4 (550.2144)

(11aR)-3,7-Bis(2,4,6-trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1,7-fg][1,3,2]dioxaphosphocin

C35H35O4P (550.2273)

acetic acid 5-[3-(4-acetoxypyrrolidin-2-ylmethyl)-6,6’-difluoro-1H,1H-[2,2]biindolyl-3-ylmethyl]pyrrolidin-3-yl ester

C30H32F2N4O4 (550.2391)

gentamicin A (2)-phosphate

C18H39N4O13P+2 (550.2251)

Tobramycin 2-phosphate

C18H41N5O12P+3 (550.2489)

Manumycin A

C31H38N2O7 (550.2679)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors

PA(2:0/PGF2alpha)

C25H43O11P (550.2543)

PA(PGF2alpha/2:0)

C25H43O11P (550.2543)

PA(2:0/PGE1)

C25H43O11P (550.2543)

PA(PGE1/2:0)

C25H43O11P (550.2543)

PA(2:0/PGD1)

C25H43O11P (550.2543)

PA(PGD1/2:0)

C25H43O11P (550.2543)

8-Methyl-8-desvinylprotoporphyrin

C33H34N4O4 (550.258)

Alpinnanin B

C35H34O6 (550.2355)

A natural product found in Alpinia katsumadai.

ent-Alpinnanin B

C35H34O6 (550.2355)

A natural product found in Alpinia katsumadai.

ent-Alpinnanin A

C35H34O6 (550.2355)

A natural product found in Alpinia katsumadai.

Chisomicine A

C32H38O8 (550.2567)

A natural product found in Chisocheton ceramicus.

methyl (1beta,11beta,12alpha,15beta)-15-{[(2E)-3,4-dimethylpent-2-enoyl]oxy}-1,11,12-trihydroxy-2,16-dioxo-13,20-epoxypicrasan-21-oate

C28H38O11 (550.2414)

Glu-Phe-Gln-Gln

C24H34N6O9 (550.2387)

A tetrapeptide composed of L-glutamic acid, L-phenylalanine and two L-glutamine units joined by peptide linkages.

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide

C30H34N2O6S (550.2137)

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide

C30H34N2O6S (550.2137)

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide

C30H34N2O6S (550.2137)

(R)-2,4,6-Trimethyl-deca-2,4-dienoic acid {(1S,5S,6R)-5-hydroxy-5-[(1E,3E,5E)-6-(2-hydroxy-5-oxo-cyclopent-1-enylcarbamoyl)-hexa-1,3,5-trienyl]-2-oxo-7-oxa-bicyclo[4.1.0]hept-3-en-3-yl}-amide

C31H38N2O7 (550.2679)

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide

C30H34N2O6S (550.2137)

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide

C30H34N2O6S (550.2137)

1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea

C27H36Cl2N4O4 (550.2113)

1-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea

C27H36Cl2N4O4 (550.2113)

1-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea

C27H36Cl2N4O4 (550.2113)

1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea

C27H36Cl2N4O4 (550.2113)

1-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea

C27H36Cl2N4O4 (550.2113)

N-[(2R,3R)-2-[[[(4-fluoroanilino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

C28H31FN6O5 (550.234)

N-[(2S,3S)-2-[[[(4-fluoroanilino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

C28H31FN6O5 (550.234)

2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide

C30H34N2O6S (550.2137)

1-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea

C27H36Cl2N4O4 (550.2113)

1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea

C27H36Cl2N4O4 (550.2113)

1-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea

C27H36Cl2N4O4 (550.2113)

1-[(2S,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea

C26H35FN4O6S (550.2261)

1-[(2S,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea

C26H35FN4O6S (550.2261)

N-[(2S,3R)-2-[[[(4-fluoroanilino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

C28H31FN6O5 (550.234)

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide

C30H34N2O6S (550.2137)

2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide

C30H34N2O6S (550.2137)

(2E,4E,6R)-N-[(5S,6R)-5-[(1E,3E,5E)-7-[(2,5-dioxocyclopentyl)amino]-7-oxohepta-1,3,5-trienyl]-5-hydroxy-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienamide

C31H38N2O7 (550.2679)

(2S)-2-[[(2S)-2-[(1-ethoxycarbonylpiperidin-4-yl)oxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid

C22H38N4O10S (550.2309)

[1-[(4E,7E)-deca-4,7-dienoyl]oxy-3-phosphonooxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C29H43O8P (550.2695)

bruceanol E

C28H38O11 (550.2414)

A quassinoid that is the dihydro derivative of bruceanol D. Isolated from Brucea antidysenterica, it exhibits in vitro cytotoxicity towards several human tumour cell lines.

SQMG 16:3

C25H42O11S (550.2448)

PA 14:0/8:3;O3

C25H43O11P (550.2543)

PA 14:1/8:2;O3

C25H43O11P (550.2543)

PA 22:3;O3

C25H43O11P (550.2543)

PA 22:6/4:1

C29H43O8P (550.2695)

PA 26:7

C29H43O8P (550.2695)

LPGP 15:0

C21H44O12P2 (550.2308)

LPGP O-16:0

C22H48O11P2 (550.2672)

PM 25:7

C29H43O8P (550.2695)

ST 18:0;O8;GlcA

C24H38O14 (550.2261)

ST 22:4;O5;GlcA

C28H38O11 (550.2414)

ST 19:0;O8;Hex

C25H42O13 (550.2625)

ST 22:5;O6;Hex

C28H38O11 (550.2414)

ST 25:1;O8;S

C25H42O11S (550.2448)

ST 28:6;O6;S

C28H38O9S (550.2236)

ST 29:5;O5;S

C29H42O8S (550.26)

SOS1-IN-14

C29H29F3N6O2 (550.2304)

SOS1-IN-14 is a potent, selective and orally active SOS1 inhibitor with an IC50 value of 3.9 nM. SOS1-IN-14 can be absorbed in the intestine via a P-glycoprotein-mediated efflux mechanism. SOS1-IN-14 can be used to research KRAS-mutated cancers. SOS1-IN-14 has better potent tumor suppression than BI-3406 (HY-125817)[1].

(9ar,11as)-1-{2-hydroxy-1-[5-(methoxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl}-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthrene-7-sulfonic acid

C29H42O8S (550.26)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 5-[7-(acetyloxy)-4,9-dimethyl-11-oxo-10-oxatricyclo[6.3.2.0¹,⁷]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoate

C28H38O11 (550.2414)

(3r,4r)-4-{[(2s,3r)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]methyl}-3-[(4-hydroxy-3-methoxyphenyl)methyl]-4-methyloxolan-2-one

C31H34O9 (550.2203)

2,10,14-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate

C28H38O11 (550.2414)

[(1s,2s,3s,4r,7s,8e,12s,13s,14r)-2,12,14-tris(acetyloxy)-3-hydroxy-4,13,17-trimethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-9-yl]methyl acetate

C28H38O11 (550.2414)

(9r,13s,16s,17r,18s)-16-[(1r)-1-hydroxy-1-[(2s)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-8,8,13,17-tetramethyl-6,15-dioxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4,10-tetraen-18-yl acetate

C32H38O8 (550.2567)

(2e,4e,6r)-n-[(1s,5s,6r)-5-hydroxy-5-[(1e,3e,5e)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienimidic acid

C31H38N2O7 (550.2679)

(1r,2s,5r,6r,13s,14r,16s)-6-(furan-3-yl)-16-(2-methoxy-2-oxoethyl)-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadeca-9,11-dien-14-yl (2z)-2-methylbut-2-enoate

C32H38O8 (550.2567)

methyl (3as,4s,5s,11ar)-4-{[(2s,3r)-3-(acetyloxy)-2-hydroxy-2-methylbutanoyl]oxy}-10-methyl-5-{[(2s)-2-methylbutanoyl]oxy}-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate

C28H38O11 (550.2414)

alpinnanin a

C35H34O6 (550.2355)

{"Ingredient_id": "HBIN015752","Ingredient_name": "alpinnanin a","Alias": "NA","Ingredient_formula": "C35H34O6","Ingredient_Smile": "COC1=C(C(=C(C(=C1)O)C(C=CCC(CCC2=CC=CC=C2)O)C3=CC=C(C=C3)O)O)C(=O)C=CC4=CC=CC=C4","Ingredient_weight": "550.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "986","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11613685","DrugBank_id": "NA"}

alpinnanin c

C35H34O6 (550.2355)

{"Ingredient_id": "HBIN015754","Ingredient_name": "alpinnanin c","Alias": "NA","Ingredient_formula": "C35H34O6","Ingredient_Smile": "COC1=C(C(=C(C(=C1)O)C(CC(CCC2=CC=CC=C2)O)C=CC3=CC=C(C=C3)O)O)C(=O)C=CC4=CC=CC=C4","Ingredient_weight": "550.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "988","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11678391","DrugBank_id": "NA"}

10'-hydroxy-1',6,6',9,10'-pentamethyl-2,5',7-trioxo-4,5,9a,9b-tetrahydro-3ah-4'-oxaspiro[azuleno[4,5-b]furan-3,14'-tetracyclo[10.2.1.0²,¹¹.0³,⁷]pentadecan]-2'(11')-en-8'-yl acetate

C32H38O8 (550.2567)

[(1s,2s,3e,7r,8z,10r,13s)-9,10,13-tris(acetyloxy)-2,7-dihydroxy-8,12,15,15-tetramethyl-5-oxobicyclo[9.3.1]pentadeca-3,8,11-trien-4-yl]methyl acetate

C28H38O11 (550.2414)

2,5,7-tris(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-9-yl acetate

C28H38O11 (550.2414)

(1s,2r,5r,6s,7s,8r,9r,12r)-12-(acetyloxy)-7-(benzoyloxy)-5-hydroxy-2,6,10,10-tetramethyl-4-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

C31H34O9 (550.2203)

(1r,2s,4r,5r,6r,7r,9s)-4-(acetyloxy)-5-(benzoyloxy)-2-hydroxy-2,6,10,10-tetramethyl-12-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C31H34O9 (550.2203)

1-{2,4-dihydroxy-3-[5-hydroxy-1-(4-hydroxyphenyl)-7-phenylhept-1-en-3-yl]-6-methoxyphenyl}-3-phenylprop-2-en-1-one

C35H34O6 (550.2355)

[(1s,2s,3r,4r,7s,8e,12s,13r,14s)-2,12,14-tris(acetyloxy)-3-hydroxy-4,13-dimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-9-yl]methyl acetate

C28H38O11 (550.2414)

5,5-dimethyl-4-(3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one

C25H42O13 (550.2625)

(2e)-1-{2,4-dihydroxy-3-[(2e)-5-hydroxy-1-(4-hydroxyphenyl)-7-phenylhept-2-en-1-yl]-6-methoxyphenyl}-3-phenylprop-2-en-1-one

C35H34O6 (550.2355)

(1s,2r,3s,4r,7s,8z,10r,12r,13r,14s)-10,12,14-tris(acetyloxy)-3-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-2-yl acetate

C28H38O11 (550.2414)

(1s,2r,3r,4r,7s,8z,10r,12s,13r,14s)-10,12,14-tris(acetyloxy)-3-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-2-yl acetate

C28H38O11 (550.2414)

[(1s,4s,5s,6r,9s,10r,11r,12r,14r)-5,6-dihydroxy-7-(hydroxymethyl)-3,11,14-trimethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl]methyl benzoate

C32H38O8 (550.2567)

(1r,2s,3r,4r,7s,8z,10r,12s,13s,14s)-2,10,14-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate

C28H38O11 (550.2414)

2,5,10-tris(acetyloxy)-7-hydroxy-4,14,16,16-tetramethyl-8-methylidene-13-oxo-15-oxatetracyclo[9.4.1.0¹,¹⁴.0⁴,⁹]hexadecan-3-yl acetate

C28H38O11 (550.2414)

(2s)-2-methyl-1-[9,12,14-trihydroxy-13-(2-hydroxy-3-methylbut-3-en-1-yl)-5,5-dimethyl-8-[(2s)-2-methylbutanoyl]-6,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,8,11(16),12,14-heptaen-15-yl]butan-1-one

C32H38O8 (550.2567)

(1s,2s,3s,4r,7s,8z,12s,13s,14r,15s)-2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate

C28H38O11 (550.2414)

(4s,7s,18s,21s)-3,9,17,23-tetrahydroxy-4,5,7,18,19,21-hexamethyl-2,5,8,16,19,22-hexaazatricyclo[22.4.0.0¹⁰,¹⁵]octacosa-1(28),2,8,10,12,14,16,22,24,26-decaene-6,20-dione

C28H34N6O6 (550.254)

(4r)-3-(hydroxymethyl)-5,5-dimethyl-4-[(3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl]cyclohex-2-en-1-one

C25H42O13 (550.2625)

[(1s,2s,3r,6s,8r,9r,10r,11r,12s,13r)-8-acetyl-3-{[(2e)-3,4-dimethylpent-2-enoyl]oxy}-11,12-dihydroxy-13-(methoxycarbonyl)-9-methyl-4-oxo-14-oxatetracyclo[8.5.0.0¹,⁶.0²,¹³]pentadecan-9-yl]acetic acid

C28H38O11 (550.2414)

[(1s,4s,5r,6r,9s,10r,11r,12r,14r)-4,5,6-trihydroxy-3,11,14-trimethyl-7-({[(2z)-2-methylbut-2-enoyl]oxy}methyl)-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl]methyl benzoate

C32H38O8 (550.2567)

(1s,2s,3r,4r,7s,8z,12s,13s,14r,15s)-2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate

C28H38O11 (550.2414)

methyl 4-{[3-(acetyloxy)-2-hydroxy-2-methylbutanoyl]oxy}-10-methyl-5-[(2-methylbutanoyl)oxy]-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate

C28H38O11 (550.2414)

(1s,4r,11r,14s,17s,20r)-4-[(2s)-butan-2-yl]-14-[(1r)-1-hydroxyethyl]-17-isopropyl-11,20-dimethyl-19-oxa-6-thia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-2,5(22),7,9,12,15,18(21)-heptaene-2,9,12,15-tetrol

C25H38N6O6S (550.2573)

(2e)-1-{2,4-dihydroxy-3-[(1s,2e,5r)-5-hydroxy-1-(4-hydroxyphenyl)-7-phenylhept-2-en-1-yl]-6-methoxyphenyl}-3-phenylprop-2-en-1-one

C35H34O6 (550.2355)

4-hydroxy-3,5,5-trimethyl-4-(3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl)cyclohex-2-en-1-one

C25H42O13 (550.2625)

(1s,2s,3r,5r,8s,9z,11r,13s,14r,15s,17s,19r)-11,15-bis(acetyloxy)-2-hydroxy-5,10,14,19-tetramethyl-6-oxo-4,7,18-trioxapentacyclo[12.5.0.0³,⁵.0³,⁸.0¹⁷,¹⁹]nonadec-9-en-13-yl butanoate

C28H38O11 (550.2414)

(1s,2s,4s,7r,8r,9s,10s,12s,13s,16r)-7,8,10-tris(acetyloxy)-12,13-dihydroxy-5,9-dimethyl-2-(prop-1-en-2-yl)-15-oxatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadec-5-en-4-yl acetate

C28H38O11 (550.2414)

2-(hydroxymethyl)-6-{[1,5,5-trimethyl-6-(3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl)-7-oxabicyclo[4.1.0]heptan-3-yl]oxy}oxane-3,4,5-triol

C25H42O13 (550.2625)

(1s,2s,3r,4r,7s,8z,10r,12s,13r,14s)-2,10,14-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate

C28H38O11 (550.2414)

methyl (1r,2s,3r,6r,8s,9r,11s,13s,14s,15r,16s,17s)-3-{[(2e)-3,4-dimethylpent-2-enoyl]oxy}-11,15,16-trihydroxy-9,13-dimethyl-4,12-dioxo-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadecane-17-carboxylate

C28H38O11 (550.2414)

(1s,2r,3s,4r,5s,7s,8s,9s,12z,14s,17r)-2,5,7-tris(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-9-yl acetate

C28H38O11 (550.2414)

(1r,2r,3r,4s,7r,8z,12r,13r,14s,15r)-2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate

C28H38O11 (550.2414)

9,13,15-tris(acetyloxy)-14-hydroxy-6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15h,15ah-cyclotetradeca[b]furan-4-yl acetate

C28H38O11 (550.2414)

2-[4,8-bis(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl acetate

C28H38O11 (550.2414)

methyl (1r,2s,6r,8s,9r,13s,14s,15r)-3-{[(2e)-3,4-dimethylpent-2-enoyl]oxy}-11,15,16-trihydroxy-9,13-dimethyl-4,12-dioxo-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadecane-17-carboxylate

C28H38O11 (550.2414)

(1s,2r,3s,4r,7s,8z,10r,12r,13r,14s)-10,12,14-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate

C28H38O11 (550.2414)

3,9,17,23-tetrahydroxy-4,5,7,18,19,21-hexamethyl-2,5,8,16,19,22-hexaazatricyclo[22.4.0.0¹⁰,¹⁵]octacosa-1(28),2,8,10,12,14,16,22,24,26-decaene-6,20-dione

C28H34N6O6 (550.254)

(2e)-1-{2,4-dihydroxy-3-[(1e,3r,5s)-5-hydroxy-1-(4-hydroxyphenyl)-7-phenylhept-1-en-3-yl]-6-methoxyphenyl}-3-phenylprop-2-en-1-one

C35H34O6 (550.2355)

2-(acetyloxy)-1-[7,14-bis(acetyloxy)-7-methyl-2-methylidene-5,13-dioxatricyclo[8.4.0.0⁴,⁶]tetradec-11-en-11-yl]-2-(3,3-dimethyloxiran-2-yl)ethyl acetate

C28H38O11 (550.2414)

(1r,2r,3r,4s,7r,8z,12r,13r,14r,16s)-2,14,16-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate

C28H38O11 (550.2414)

(1r,2s,3r,4s,5s,7s,9r,10r,11r,14s)-2,5,10-tris(acetyloxy)-7-hydroxy-4,14,16,16-tetramethyl-8-methylidene-13-oxo-15-oxatetracyclo[9.4.1.0¹,¹⁴.0⁴,⁹]hexadecan-3-yl acetate

C28H38O11 (550.2414)

2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate

C28H38O11 (550.2414)

2,10,14-tris(acetyloxy)-3-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-12-yl acetate

C28H38O11 (550.2414)

(1s,2s,3s,4r,5s,7s,8s,9r,12z,14s,17r)-5,7,9-tris(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-2-yl acetate

C28H38O11 (550.2414)

(1r,2r)-2-(acetyloxy)-1-[(1r,4r,6r,7s,10s,14r)-7,14-bis(acetyloxy)-7-methyl-2-methylidene-5,13-dioxatricyclo[8.4.0.0⁴,⁶]tetradec-11-en-11-yl]-2-[(2r)-3,3-dimethyloxiran-2-yl]ethyl acetate

C28H38O11 (550.2414)

[2,12,14-tris(acetyloxy)-3-hydroxy-4,13-dimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-9-yl]methyl acetate

C28H38O11 (550.2414)

(1s,2s,3r,5r,8s,9z,12r,13r,14r,15s,17s,19r)-12,15-bis(acetyloxy)-2-hydroxy-5,10,14,19-tetramethyl-6-oxo-4,7,18-trioxapentacyclo[12.5.0.0³,⁵.0³,⁸.0¹⁷,¹⁹]nonadec-9-en-13-yl butanoate

C28H38O11 (550.2414)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,3s,6s)-1,5,5-trimethyl-6-[(1e,3s)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]-7-oxabicyclo[4.1.0]heptan-3-yl]oxy}oxane-3,4,5-triol

C25H42O13 (550.2625)

(1s,2r,3s,4r,5s,7s,8s,9r,12z,14s,17r)-5,7,9-tris(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-2-yl acetate

C28H38O11 (550.2414)

(3ar,4r,9s,13r,14s,15s,15as)-4,9,13-tris(acetyloxy)-14-hydroxy-6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15h,15ah-cyclotetradeca[b]furan-15-yl acetate

C28H38O11 (550.2414)

12-(acetyloxy)-7-(benzoyloxy)-5-hydroxy-2,6,10,10-tetramethyl-4-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

C31H34O9 (550.2203)

[(1r,2s,3e,7r,8e,10r,13s)-9,10,13-tris(acetyloxy)-2,7-dihydroxy-8,12,15,15-tetramethyl-5-oxobicyclo[9.3.1]pentadeca-3,8,11-trien-4-yl]methyl acetate

C28H38O11 (550.2414)

(1r,2r,3s,4r,5s,7s,8s,9r,12z,14s,17r)-5,7,9-tris(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-2-yl acetate

C28H38O11 (550.2414)

(4,5,6-trihydroxy-3,11,14-trimethyl-7-{[(2-methylbut-2-enoyl)oxy]methyl}-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl)methyl benzoate

C32H38O8 (550.2567)

[(1r,2s,3z,7r,8e,10r,13s)-9,10,13-tris(acetyloxy)-2,7-dihydroxy-8,12,15,15-tetramethyl-5-oxobicyclo[9.3.1]pentadeca-3,8,11-trien-4-yl]methyl acetate

C28H38O11 (550.2414)

methyl (3as,4s,5s,11ar)-4-{[(2s,3s)-3-(acetyloxy)-2-hydroxy-2-methylbutanoyl]oxy}-10-methyl-5-{[(2r)-2-methylbutanoyl]oxy}-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate

C28H38O11 (550.2414)

2,14,16-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate

C28H38O11 (550.2414)

methyl (2r,3r,6r,8s,9r,12s,13s,14s,15r,16r,17r)-3-{[(2e)-3,4-dimethylpent-2-enoyl]oxy}-12,15,16-trihydroxy-9,13-dimethyl-4,11-dioxo-5,19-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadecane-17-carboxylate

C28H38O11 (550.2414)

16-[1-hydroxy-1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-8,8,13,17-tetramethyl-6,15-dioxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4,10-tetraen-18-yl acetate

C32H38O8 (550.2567)

(1's,3r,3's,3as,6's,7'r,8's,9as,9bs,10'r,12's)-10'-hydroxy-1',6,6',9,10'-pentamethyl-2,5',7-trioxo-4,5,9a,9b-tetrahydro-3ah-4'-oxaspiro[azuleno[4,5-b]furan-3,14'-tetracyclo[10.2.1.0²,¹¹.0³,⁷]pentadecan]-2'(11')-en-8'-yl acetate

C32H38O8 (550.2567)

1-{2,4-dihydroxy-3-[5-hydroxy-1-(4-hydroxyphenyl)-7-phenylhept-2-en-1-yl]-6-methoxyphenyl}-3-phenylprop-2-en-1-one

C35H34O6 (550.2355)

4-{[2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]methyl}-3-[(4-hydroxy-3-methoxyphenyl)methyl]-4-methyloxolan-2-one

C31H34O9 (550.2203)

14-(1-hydroxyethyl)-17-isopropyl-11,20-dimethyl-4-(sec-butyl)-19-oxa-6-thia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-2,5(22),7,9,12,15,18(21)-heptaene-2,9,12,15-tetrol

C25H38N6O6S (550.2573)

3-(hydroxymethyl)-5,5-dimethyl-4-(3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl)cyclohex-2-en-1-one

C25H42O13 (550.2625)

(1s,2s,7r,8r,9s,10s,12s,13s,16r)-7,8,10-tris(acetyloxy)-12,13-dihydroxy-5,9-dimethyl-2-(prop-1-en-2-yl)-15-oxatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadec-4-en-4-yl acetate

C28H38O11 (550.2414)

7,8,10-tris(acetyloxy)-12,13-dihydroxy-5,9-dimethyl-2-(prop-1-en-2-yl)-15-oxatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadec-5-en-4-yl acetate

C28H38O11 (550.2414)

(4s)-4-hydroxy-3,5,5-trimethyl-4-[(3s)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl]cyclohex-2-en-1-one

C25H42O13 (550.2625)

2,9-bis(acetyloxy)-4,5-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadeca-6,12-dien-11-yl butanoate

C28H38O11 (550.2414)

[9,10,13-tris(acetyloxy)-2,7-dihydroxy-8,12,15,15-tetramethyl-5-oxobicyclo[9.3.1]pentadeca-3,8,11-trien-4-yl]methyl acetate

C28H38O11 (550.2414)

(4s)-5,5-dimethyl-4-[(3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one

C25H42O13 (550.2625)

4-(acetyloxy)-5-(benzoyloxy)-2-hydroxy-2,6,10,10-tetramethyl-12-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C31H34O9 (550.2203)

(2e,4e,6r)-n-[(1s,5r,6r)-5-hydroxy-5-[(1e,3e,5e)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienimidic acid

C31H38N2O7 (550.2679)

n-[(1r,5s,6r)-5-hydroxy-5-{6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienimidic acid

C31H38N2O7 (550.2679)

(1r,2s,4r,5r,6r,7s,9s)-4-(acetyloxy)-5-(benzoyloxy)-2-hydroxy-2,6,10,10-tetramethyl-12-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C31H34O9 (550.2203)

(1s,2s,3s,4r,7s,8z,10r,12s,13r,14s)-2,10,14-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate

C28H38O11 (550.2414)

[5,6-dihydroxy-7-(hydroxymethyl)-3,11,14-trimethyl-4-[(2-methylbut-2-enoyl)oxy]-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl]methyl benzoate

C32H38O8 (550.2567)